High-dose therapy and autologous hematopoietic progenitor cell transplantation for recurrent or refractory Hodgkin's disease: analysis of the Stanford University results and prognostic indices.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples